Program

585
107
103
99
36
3
769
26
22
16
11
10
10
9
4

Journal Year Published

21
94
73
129
80
82
75
65
51
40
40
29
14
4
3
2

Author

183
155
134
133
127
118
118
114
108
90
86
81
69
57
52
50
43
42
42
34

Category

340
309
283
84
69
49
21
19
12
9
3
2

Keyword

367
210
114
110
88
79
74
70
66
59
54
53
46
45
40
40
37
35
35
34

Journal

47
37
28
28
25
24
20
16
14
14
13
12
12
11
10
10
9
9
9
8

NCATS Publications

Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding Sites.


Luderman KD, Conroy JL, Free RB, Southall N, Ferrer-Alegre M, Sanchez-Soto M, Moritz AE, Willette BKA, Fyfe TJ, Jain P, Titus S, Hazelwood LA, Aubé J, Lane JR, Frankowski KJ, Sibley DR


Mol. Pharmacol. , (94), 1197-1209, 2018.

Article Pubmed

Sample image from publication page

Comprehensive Analyses and Prioritization of Tox21 10K Chemicals Affecting Mitochondrial Function by in-Depth Mechanistic Studies.


Xia M, Huang R, Shi Q, Boyd WA, Zhao J, Sun N, Rice JR, Dunlap PE, Hackstadt AJ, Bridge MF, Smith MV, Dai S, Zheng W, Chu P, Gerhold D, Witt KL, DeVito M, Freedman JH, Austin C, Houck KA, Thomas RS, Paules RS, Tice RR, Simeonov A


Environ. Health Perspect. , (126), 077010, 2018.

Article Pubmed

Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy.


Feliz-Mosquea YR, Christensen AA, Wilson AS, Westwood B, Varagic J, Meléndez GC, Schwartz AL, Chen QR, Mathews Griner L, Guha R, Thomas C, Ferrer-Alegre M, Merino MJ, Cook KL, Roberts DD, Soto-Pantoja DR


Breast Cancer Res. Treat. , (172), 69-82, 2018.

Article Pubmed

miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential.


Meyer SE, Muench DE, Rogers AM, Newkold TJ, Orr E, O'Brien E, Perentesis JP, Doench JG, Lal A, Morris P, Thomas C, Lieberman J, McGlinn E, Aronow BJ, Salomonis N, Grimes HL


J. Exp. Med. , (215), 2115-2136, 2018.

Article Pubmed

Sample image from publication page

MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma.


Yohe ME, Gryder BE, Shern JF, Song YK, Chou HC, Sindiri S, Mendoza A, Patidar R, Zhang X, Guha R, Butcher D, Isanogle KA, Robinson CM, Luo X, Chen JQ, Walton A, Awasthi P, Edmondson EF, Difilippantonio S, Wei JS, Zhao K, Ferrer-Alegre M, Thomas C, Khan J


Sci Transl Med , (10), 2018.

Article Pubmed

Sample image from publication page